SMS Lifesciences India receives EIR with VAI status from USFDA for API facility at Kazipally
The receipt of EIR reaffirms the company's commitment to maintaining global quality standards
The receipt of EIR reaffirms the company's commitment to maintaining global quality standards
The company has reported total income of Rs. 75.26 crores during the period ended June 30, 2023
Subscribe To Our Newsletter & Stay Updated